New drug targets gene flaw in Tough-to-Treat cancers
Disease control
Not yet recruiting
This study is testing an investigational drug called SC-101 for people with advanced breast cancer and other solid tumors that have a specific genetic feature called NECTIN4 amplification. About 120 participants whose cancer has progressed after standard treatments will receive w…
Phase: PHASE2 • Sponsor: Tianjin ConjuStar Biologics Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC